APA (7th ed.) Citation

Keshteli, A. H., Madsen, K. L., Mandal, R., Boeckxstaens, G. E., Bercik, P., De Palma, G., . . . Dieleman, L. A. (2019). Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: New insights into pathophysiology and potential biomarkers. Alimentary pharmacology & therapeutics, 49(6), 723-732. https://doi.org/10.1111/apt.15141

Chicago Style (17th ed.) Citation

Keshteli, Ammar Hassanzadeh, et al. "Comparison of the Metabolomic Profiles of Irritable Bowel Syndrome Patients with Ulcerative Colitis Patients and Healthy Controls: New Insights into Pathophysiology and Potential Biomarkers." Alimentary Pharmacology & Therapeutics 49, no. 6 (2019): 723-732. https://doi.org/10.1111/apt.15141.

MLA (9th ed.) Citation

Keshteli, Ammar Hassanzadeh, et al. "Comparison of the Metabolomic Profiles of Irritable Bowel Syndrome Patients with Ulcerative Colitis Patients and Healthy Controls: New Insights into Pathophysiology and Potential Biomarkers." Alimentary Pharmacology & Therapeutics, vol. 49, no. 6, 2019, pp. 723-732, https://doi.org/10.1111/apt.15141.